Prosecution Insights
Last updated: October 25, 2026

Amjad A Abraham, USPTO Patent Examiner

Listed by the USPTO as ABRAHAM, AMJAD A

Tech Center 3700 • Art Units: 1600 1662 1663 1744 1791 3797

This examiner grants 32% of resolved cases

Analysis

ABRAHAM, AMJAD A is assigned to Tech Center 3700 and Art Unit 1600, with 335 resolved cases. The profile shows a 31.6% allowance rate and a median of 1232 days to allowance. The 35.4% interview lift indicates a strong positive association between interviews and allowance outcomes despite the limited overall allowance result.

M.S. Technologies LLC, Mary Kay Inc., and Gdm Seeds Inc. are the leading companies represented. CANTOR COLBURN LLP, COOLEY LLP, and DENTONS US LLP are the leading firms shown. Practitioners may find interviews particularly important, but the low allowance rate and long median timing also support disciplined claim assessment and early planning for continued examination.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

31.6%
Allow Rate
-38.4% vs TC avg
348
Total Applications
+35.4%
Interview Lift
1232
Avg Prosecution Days
Based on 335 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
16.0%
§102 Novelty
52.3%
§103 Obviousness
22.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18587098 METHOD AND COMPOSITION FOR ENHANCING IMMUNE SYSTEM Final Rejection Individual inventor
18370794 SOYBEAN CULTIVAR 28030716 Final Rejection M.S. Technologies, L.L.C.
18387319 PORE MINIMIZER Non-Final OA MARY KAY INC.
18523647 SOYBEAN VARIETIES '2993027', '3379006', '21808483', '21775353', '21775373', AND '21776015' Non-Final OA GDM Seeds Inc.
18979328 COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS Non-Final OA DERMATA THERAPEUTICS, INC.
18214183 PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES Final Rejection Housey Pharmaceutical Research Laboratories, L.L.C.
17372080 ORAL ADMINISTRATION OF MELANIN FOR PROTECTION AGAINST RADIATION Non-Final OA ALBERT EINSTEIN COLLEGE OF MEDICINE
18682255 Oral Rinse Formulations Having Essential Oils Non-Final OA ProSANUS LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amjad A Abraham's allowance rate?

31.6% of resolved applications examined by Amjad A Abraham were allowed (335 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.

Does an interview help with examiner Amjad A Abraham?

This examiner's interview lift is +35.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amjad A Abraham take to allow a patent?

Applications allowed by Amjad A Abraham took 1,232 days on average from filing to allowance.

Which art unit does examiner Amjad A Abraham work in?

Amjad A Abraham examines applications in Art Unit 1600 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month